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OBJECTIVE: To examine inpatient intensive care unit
(ICU) and intensive procedure use by race among
Medicare decedents, using utilization among survivors
for comparison.
DESIGN: Retrospective observational analysis of inpa-
tient claims using multivariable hierarchical logistic
regression.
SETTING: United States, 1989–1999.
PARTICIPANTS: Hospitalized Medicare fee-for-service
decedents (n=976,220) and survivors (n=845,306) aged
65 years or older.
MEASUREMENTS AND MAIN RESULTS: Admission to
the ICU and use of one or more intensive procedures
over 12 months, and, for inpatient decedents, during
the terminal admission. Black decedents with one or
more hospitalization in the last 12 months of life were
slightly more likely than nonblacks to be admitted to
the ICU during the last 12 months (49.3% vs. 47.4%, p<
.0001) and the terminal hospitalization (41.9% vs.
40.6%, p<0.0001), but these differences disappeared
or attenuated in multivariable hierarchical logistic
regressions (last 12 months adjusted odds ratio (AOR)
1.0 [0.99–1.03], p=.36; terminal hospitalization AOR
1.03 [1.0–1.06], p=.01). Black decedents were more
likely to undergo an intensive procedure during the last
12 months (49.6% vs. 42.8%, p<.0001) and the termi-
nal hospitalization (37.7% vs, 31.1%, p<.0001), a
difference that persisted with adjustment (last
12 months AOR 1.1 [1.08–1.14], p<.0001; terminal
hospitalization AOR 1.23 [1.20–1.26], p<.0001). Pat-
terns of differences in inpatient treatment intensity by
race were reversed among survivors: blacks had lower
rates of ICU admission (31.2% vs. 32.4%, p<.0001;
AOR 0.93 [0.91–0.95], p<.0001) and intensive proce-
dure use (36.6% vs. 44.2%; AOR 0.72 [0.70–0.73], p<
.0001). These differences were driven by greater use by
blacks of life-sustaining treatments that predominate
among decedents but lesser use of cardiovascular and
orthopedic procedures that predominate among survi-
vors. A hospital’s black census was a strong predictor of
inpatient end-of-life treatment intensity.
CONCLUSIONS: Black decedents were treated more
intensively during hospitalization than nonblack dece-
dents, whereas black survivors were treated less inten-
sively. These differences are strongly associated with a
hospital’s black census. The causes and consequences
of these hospital-level differences in intensity deserve
further study.
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I
n contrast to general patterns of racial differences in health
care utilization,
1,2 including lower rates of invasive cardiac
procedures,
3–11 surgical treatment for lung cancer
12 and renal
transplantation
13,14 among blacks, at the end of life, blacks
appear to receive higher rates of intensive treatment. For
example, blacks are more likely to die in the hospital
15 and
less likely to use hospice
16 and have higher overall spending in
their last 12 months than whites.
17–19 Some have tried to
explain these phenomena by citing differences in patient
preferences. Indeed, several studies report that blacks and
Hispanics prefer more aggressive life-sustaining treatment
than whites,
20–23 and that physicians’ preferences for end-of-
life treatment follow the same pattern by race as patients’
preferences.
24 However, treatment preferences for care at the
end of life do not reliably predict actual treatment.
15,25
Recent studies have explored the role of region,
26 hospi-
tal,
27–29 and individual provider
30 in observed racial differ-
ences in health care utilization. With respect to end-of-life care,
an analysis of Medicare claims found that aggregate ICU
admissions and hospital days in the last 6 months of life are
driven more by region of residence than by race
31 and an
analysis of terminal hospital discharges from 6 states found
that the majority of observed differences in ICU use among
black and Hispanic decedents were attributable to their use of
hospitals with higher ICU use rather than to racial differences
in ICU use within the same hospital.
32
Secular increases in ICU admission and intensive inpatient
procedure use have occurred among both decedents and
survivors
33; little is known about the respective trends by
race. Building upon our previous work, we sought to describe
the effect of race on inpatient ICU and intensive procedure use
among Medicare decedents over 10 years, adjusting for
hospital-level effects in the analyses and using utilization
among survivors for comparison. We hypothesized that hospi-
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338talized black decedents would be treated more intensively in
their last 12 months of life, but less intensively otherwise, and
that differences in end-of-life intensity would be largely attrib-
utable to greater use of life-sustaining procedures such as me-
chanical ventilation, feeding tube placement, and hemodialysis.
METHODS
Sample Selection
We initiallydrew a20%sample ofalldecedentsanda5%sample
of all survivors enrolled in Medicare in 1989, 1991, 1993, 1995,
1997, and 1999 from the Denominator file maintained by the
Centers for Medicare and Medicaid Services. The data were
initially assembled to study secular trends over time, so it was
not felt that every year was necessary.
33 For the current anal-
yses, we removed 1985 and 1987 because these years were not
comparable to the years after 1989, due to the introduction of
DRGs 474 and 475 in October, 1987. After those DRGs were
introduced, there was a marked jump in the coding of intuba-
tion and tracheostomy procedures, the most common inpatient
intensive procedures among decedents. Regarding truncation
at 1999, at the time of our initial forays into analysis (2001),
1999 was the most recent year of data available.
For each beneficiary, we assembled the acute care hospital
claims from the Medicare Medical Provider Analysis and
Review (MedPAR) files; for decedents, we included all claims
in the 365 days preceding their death and for the survivors we
included claims during the calendar year. This provided a full
12 months of enrollment and utilization experience for both
survivors and decedents. We limited our analysis to patients
aged 65 and older and excluded Medicare beneficiaries with
discontinuous enrollment in Medicare Part A or Part B, resi-
dence outside the United States or a foreign hospital admis-
sion, enrollment in a health maintenance organization, or
hospitalization in a Federal hospital during the year because
these persons might have incomplete hospitalization records.
For beneficiaries whose claims spanned multiple years (first as
survivors and later as decedents), we randomly sampled one
12-month (survivor or decedent) claims period for the current
analysis so that no beneficiary appears more than once.
We abstracted each patient’s age, sex, race, and ZIP code of
residence from the Social Security Administration denomina-
tor file. We classified age into 5-year increments (65–69, 70–74,
75–79, 80–84, and >85), and analyzed race by grouping all ben-
eficiaries into the categories “black” and “nonblack,” excluding
all beneficiaries with “unknown” race.
34 We used ZIP code level
measures of income and education from the area resource file
(ARF) as proxies for these socioeconomic indicators. Individual
socioeconomic status will generally be associated with area
measures of income, with people living in wealthy areas having
more assets and socioeconomic status than people living in
poorer areas.
35,36 In exploratory multivariable regressions,
Charlson diagnoses provided better model fit for expenditures
than Elixhauser diagnoses,
37,38 so we used the presence or ab-
sence of these 18 ICD-9 clinical diagnoses for comorbidity risk
adjustment.
We attributed a beneficiary’s hospital care to the first hos-
pital patronized in the 12-month sampling frame. Among sur-
vivors and decedents with at least one hospital admission in
the year, over 60% and 40%, respectively, had only one claim;
the remainder had two or more hospitalizations. Among all
patients with at least one hospital admission, 87% of survivors
and 78% of decedents in 1999 received all of their inpatient
care at one hospital. We used files from the American Hospital
Association (AHA) survey to identify hospitals’ membership in
the Council of Teaching Hospitals (COTH), financial status (for
profit or not for profit, including government hospitals), and
bed size. A small number of hospitals care for the vast majority
of elderly black Americans.
39 We constructed a variable
“percent black” (percent of all admissions among blacks) to
capture unmeasured hospital differences that vary systemat-
ically with black census.
Inpatient ICU and Procedure Use
For each beneficiary with at least one hospital admission in the
12 months, we recorded total hospital admissions, ICU admis-
sions, and major surgical procedures. We classified a patient
as having an ICU admission if the hospitalization included one
or more days in a coronary care unit (CCUs) or an intensive
care unit (ICUs). We condensed the International Classification
of Diseases, 9th Edition (ICD-9) procedure codes into 228
categories using an algorithm nearly identical to the Clinical
Classification System (CCS) developed for the Agency for
Healthcare Research and Quality (AHRQ). For this study, we
report data on the 88 procedure categories that are performed
primarily in the inpatient setting and which were likely the
primary reason for admission (see Appendix). We made excep-
tions to this rule for a handful of technologies that were newly
introduced during the time period of study and that grew
rapidly in use (e.g., automated implantable cardioverter defi-
brillator (AICD) implantation).
Statistical Analyses
We performed all computations with SAS statistical software
(version 6.12, SAS Corporation, Cary, NC, USA). We catego-
rized patients with at least one hospital admission during the
year into 4 subgroups: black decedents, nonblack decedents,
black survivors, and nonblack survivors, and compared their
demographics, comorbidities, hospital characteristics, inpa-
tient expenditures, and ICU and intensive procedure use. We
performed multivariable logistic regression on the categorical
receipt of one or more ICU admission and the receipt of one or
more intensive procedures using a hierarchical model to adjust
for patients clustered within hospitals. We estimated this
model with the restricted maximum likelihood method, as-
suming unstructured covariance and treating hospital as a
random effect. We performed separate regressions for dece-
dents and survivors and included calendar year of observation
in all models. Due to the marked interaction between decedent
status and all outcomes, this was the most appropriate
modeling strategy. To calculate the 95% confidence intervals
on odds ratios from our parameter estimates and standard
errors, we used the Wald first-order approximation.
40
The Institutional Review Board at Stanford University
approved the study. We had complete independence from the
National Institute on Aging (NIA) in the design, conduct, and
reporting of the study.
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Characteristics of the Study Sample
The sample included 887,787 nonblack and 88,433 black
decedents and 781,980 nonblack and 63,326 black survivors
with at least one admission between 1989 and 1999. There
were significant differences in most measured covariables
between nonblacks and blacks (Table 1).
Intensive Care and Procedure Use
We present crude rates of ICU admission and the use of one or
more intensive procedures by race for all years combined in
Table 2 and by year in Figure 1. Black decedents with one or
more hospitalization in the last 12 months of life were slightly
more likely than nonblacks to be admitted to the ICU during
the last 12 months (49.3% vs. 47.4%, p<.0001) and the
terminal hospitalization (41.9% vs. 40.6%, p<.0001), but these
differences disappeared or attenuated in multivariable hierar-
chical logistic regressions (last 12 months adjusted odds ratio
(AOR) 1.0 [0.99–1.03], p=.36; terminal hospitalization AOR
1.03 [1.0–1.06], p=.01). Black decedents were more likely to
undergo an intensive procedure during the last 12 months
(49.6% vs. 42.8%, p<.0001) and the terminal hospitalization
(37.7% vs. 31.1%, p<.0001), a difference that persisted with
adjustment (last 12 months AOR 1.1 [1.08–1.14], p<.0001;
terminal hospitalization AOR 1.23 [1.20–1.26], p<.0001).
Patterns of differences in inpatient treatment intensity by race
were reversed among survivors: blacks had lower rates of ICU
admission (31.2% vs. 32.4%, p<.0001; AOR 0.93 [0.91–0.95],
p<.0001) and intensive procedure use (36.6% vs. 44.2%; AOR
0.72 [0.70–0.73], p<.0001). The black/nonblack difference in
Table 1. Characteristics of the Study Sample, by Race and Survivor Status, 1989–1999
Characteristic Decedents Survivors
Nonblack
(N=887,787)
Black
(N=88,433)
p-value Nonblack
(N=781,980)
Black
(N=63,326)
p-value
Demographics
Mean age, years 80.9 . 79.9 . <.0001 77.3 . 76.8 . <.0001
Women, % 54.1 56.3 <.0001 58.5 61.4 <.0001
College education, % 17.2 12.8 <.0001 17.8 13.4 <.0001
Median household income, $ 30,158 22,535 <.0001 30,706 23,323 <.0001
Clinical comorbidities
Old myocardial infarction, % 6.0 4.4 <.0001 4.9 3.6 <.0001
Recent myocardial infarction, % 13.1 9.9 <.0001 5.1 3.9 <.0001
Congestive heart failure, % 41.8 38.0 <.0001 16.5 18.9 <.0001
Peripheral vascular disease, % 8.8 11.9 <.0001 4.5 5.8 <.0001
Cerebrovascular disease, % 7.0 11.0 <.0001 3.4 6.4 <.0001
Dementia, % 9.7 11.4 <.0001 3.9 5.5 <.0001
Chronic obstructive pulmonary disease, % 31.5 23.6 <.0001 20.1 16.7 <.0001
Rheumatologic disease, % 2.3 1.8 <.0001 2.0 1.7 <.0001
Peptic ulcer disease, % 0.08 0.05 .0012 0.04 0.02 .0103
Mild liver disease, % 1.8 1.4 <.0001 0.6 0.6 .0507
Moderate or severe liver disease, % 1.5 1.2 <.0001 0.3 0.2 .0204
Diabetes, % 18.8 26.3 <.0001 14.3 23.6 <.0001
Diabetes with complications, % 3.5 6.2 <.0001 1.9 4.0 <.0001
Hemiplegia, % 6.1 8.3 <.0001 2.8 4.9 <.0001
Chronic renal failure, % 8.4 13.7 <.0001 1.9 4.5 <.0001
Metastatic solid tumor, % 17.8 18.4 <.0001 3.6 3.8 .0057
Other neoplasia, % 26.2 27.5 <.0001 10.4 10.5 .374
Human immunodeficiency virus, % 0.03 0.14 <.0001 0.01 0.06 <.0001
Hospital characteristics
Size, mean number of beds 205 252 <.0001 214 257 <.0001
Member of COTH*, % 12.8 26.1 <.0001 13.6 26.0 <.0001
For profit ownership, % 10.6 11.9 <.0001 11.2 12.2 <.0001
Percent black, % 7.0 29.8 <.0001 6.4 26.5 <.0001
*Council of teaching hospitals.
Table 2. Inpatient Resource Use, by Race and Survivor Status,
1989–1999
Decedents Survivors
Nonblack (N=887,787) Black (N=88,433) p-value Nonblack (N=781,980) Black (N=63,326) p-value
Annual resource use
One or more ICU admission, % 47.4 49.3 <.0001 32.4 31.2 <.0001
Intensive procedure, % 42.8 49.6 <.0001 44.2 36.6 <.0001
Terminal admission resource use
ICU admission, % 40.6 41.9 <.0001 –– –
Intensive procedure, % 31.1 37.7 <.0001 –– –
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over time (Fig. 1).
Additional predictors of inpatient treatment intensity
included educational achievement in the patient’s ZIP code
and hospital characteristics (Table 3). Notably, a 5% increase
in the hospital’s black census increased the odds of ICU ad-
mission 17-fold ([14.1–20.8], p<.0001) for the last 12 months
and 24-fold ([18.6–31.0], p<.0001) for the terminal admis-
sion. This effect was much more modest among survivors
(AOR 1.55 [1.23–2.95], p=.0002). A 5% increase in the hos-
pital’s black census increased the odds of an intensive pro-
cedure 8-fold ([6.2–10.4], p<.0001) for the last 12 months and
16-fold ([12.6–21.1], p<.0001) for the terminal admission, but
decreased the odds for survivors more than 6-fold ([0.12–0.20],
p<0.0001).
The distinct patterns of racial differences in intensive pro-
cedure use were driven by the particular procedures that pre-
dominate among decedents compared to survivors. We list
each of the procedures performed among 1.5% or more of each
population in Table 4, indicating those that are more and less
frequently performed among blacks compared to nonblacks.
Specifically, such life-sustaining procedures as intubation/
tracheostomy for mechanical ventilation and gastrostomy
placement for enteral feeding predominated among decedents,
and blacks were more likely than nonblacks to undergo these
procedures, regardless of survivorship group. In contrast, car-
diovascular and orthopedic procedures that have been classi-
fied by the Dartmouth Atlas of Health Care as preference- and
supply-sensitive procedures, such as cardiac catheterization
and revascularization and hip replacement, predominated
Figure 1. Trends in inpatient treatment intensity differences by race between 1989 and 1999. The gap in ICU admission (panel A) and
intensive procedure use (panel B) between blacks and nonblacks has widened among decedents (dashed lines) but remained parallel or
narrowed among survivors (solid lines). Overall procedure use (panel B) among nonblacks does not vary much by survivorship status; in
contrast, procedure use among blacks is much higher for decedents than among survivors.
341 Barnato et al.: Race and EOL Inpatient Intensity JGIMamong survivors and were less frequently performed among
blacks than nonblacks.
DISCUSSION
In this retrospective observational study using fee-for-service
Medicare claims, we confirmed that black decedents were
treated more intensively during hospitalization than nonblack
decedents, whereas black survivors were treated less inten-
sively. The greater use by blacks of life-sustaining treatments
that predominate among decedents but lesser use of cardio-
vascular and orthopedic procedures that predominate among
survivors explained observed racial differences in procedure
use by survivorship cohort. The relatively smaller differences
in end-of-life ICU use were largely at]tributable to confounding
factors, including hospital choice. Among the strongest pre-
dictors of ICU and intensive procedure use was a hospital’s
black census. Because the addition of black census to the
hierarchical model decreased the size of the parameter esti-
Table 3. Adjusted Odds* of ICU Admission and Intensive Procedure Use, 1989–1999
Decedents Adjusted OR (95% CI) Survivors Adjusted OR (95% CI)
ICU admission Intensive procedure ICU admission Intensive procedure
12-Month resource use
Black race 1.01 (0.99–1.03) 1.11 (1.08–1.14) 0.93 (0.91–0.95) 0.72 (0.70–0.73)
10-Year increase in age 0.604 (0.600–0.608) 0.681 (0.675–0.686) 0.82 (0.81–0.83) 0.673 (0.668–0.679)
10% increase in college degree holders 0.04 (0.02–0.07) 0.11 (0.05–0.25) 0.02 (0.009–0.03) 1.19 (0.58–2.56)
100 bed increase in hospital size 1.066 (1.062–1.070) 1.127 (1.122–1.132) 1.064 (1.060–1.068) 1.146 (1.141–1.151)
For profit hospital 1.39 (1.37–1.41) 1.17 (1.15–1.19) 1.33 (1.31–1.35) 1.11 (1.09–1.13)
Teaching hospital 0.86 (0.85–0.88) 1.04 (1.02–1.06) 0.79 (0.78–0.81) 0.97 (0.95–0.99)
5% increase in black census 17.14 (14.14–20.79) 8.0 (6.2–10.4) 1.55 (1.23–1.95) 0.16 (0.12–0.20)
Terminal admission resource use
Black race 1.03 (1.01–1.06) 1.23 (1,20–1.26) ––
10-Year increase in age 0.545 (0.541–0.550) 0.564 (0.559–0.569) ––
10% increase in college degree holders 0.17 (0.08–0.37) 0.07 (0.03–0.16) ––
100 bed increase in hospital size 1.066 (1.061–1.071) 1.113 (1.108–1.118) ––
For profit hospital 1.31 (1.29–1.34) 1.18 (1.16–1.20) ––
Teaching hospital 0.92 (0.90–0.94) 1.13 (1.11–1.16) ––
5% increase in black census 24.05 (18.63–31.04) 16.3 (12.6–21.1) ––
*Hierarchical multivariable logistic regression model adjusted for age, race, sex, ICD-9 diagnoses of old myocardial infarction (MI), recent MI, congestive
heart failure, peripheral vascular disease, cerebrovascular disease, dementia, chronic obstructive pulmonary disease, rheumatologic disease, peptic ulcer
disease, mild liver disease, moderate–severe liver disease, diabetes, diabetes with complications, hemiplegia, chronic renal failure, neoplasia, metastatic
cancer, HIV, calendar year (1989, 1991, 1993, 1995, 1997, or 1999), ZIP code measures of education (percent of persons with a college degree) and
income (median income), and hospital characteristics, including membership in the Council of Teaching Hospitals (COTH), total hospital beds, hospital
ownership (for profit vs. not-for-profit), and the percent of decedents who were black.
Table 4. Common* Intensive Procedure Use by Race and Survivor Status, 1989–1999
Procedure Decedents Survivors
Nonblack
(N=887,787)
Black
(N=88,433)
Nonblack
(N=781,980)
Black
(N=63,326)
Greater use among blacks
Intubation and tracheostomy, % 14.5 . 19.2 . 2.0 . 2.7 .
Feeding tube placement, % 5.5 . 11.6 . 1.1 . 2.5 .
Arteriogram or venogram (not heart or head), % 2.5 . 3.1 . 2.2 . 2.8 .
Hemodialysis, % 2.2 . 5.9 . 0.6 . 2.7 .
Revision/repair of vessel/vascular procedure, % 1.3 . 2.2 . 1.1 . 2.5 .
Creation of arteriovenous fistula, % 0.7 . 2.4 . 0.3 . 1.3 .
Lesser use among blacks
Cardiac catheterization, coronary arteriography, % 4.6 . 3.1 . 8.4 . 5.7 .
Treatment, fracture of hip and femur, % 3.6 . 1.5 . 2.9 . 1.3 .
Hip replacement, total and partial, % 1.9 . 1.0 . 3.0 . 1.4 .
Insert/replace/revise/remove permanent pacemaker, % 1.6 . 1.4 . 1.9 . 1.5 .
Ileostomy and colostomy, % 1.6 . 1.5 . 0.6 . 0.5 .
Coronary artery bypass graft, % 1.6 . 0.7 . 3.1 . 1.2 .
Percutaneous transluminal coronary angioplasty, % 1.1 . 0.6 . 2.9 . 1.3 .
Knee replacement, % 0.3 . 0.2 . 2.8 . 1.7 .
Open cholecystectomy, % 1.2 . 1.1 . 1.7 . 1.2 .
Laminectomy, diskectomy, arthrodesis, % 0.4 . 0.3 . 1.7 . 0.9 .
Carotid endarterectomy, % 0.5 . 0.2 . 1.5 . 0.5 .
Little difference or variable by survivorship group
Transurethral prostatectomy, % 1.5 . 1.6 . 3.2 . 2.8 .
Colon resection, % 2.7 . 2.6 . 2.4 . 2.0 .
Excision, lysis peritoneal tissue, % 1.9 . 2.0 . 1.7 . 1.5 .
*Procedures with a prevalence of 1.5% or greater among black or nonblack decedents or survivors in the sample.
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choice/access in part mediates the observed relationship
between treatment intensity and race.
41 These systematic dif-
ferences in hospital-level practice patterns may reflect local
patient and community factors (e.g., preferences) or provider
factors (e.g., hospital resources, staffing and organization, or
process and outcomes of communication and decision making).
This is the first nationally representative study of fee-for-
service Medicare beneficiaries to explore racial differences in
ICU and intensive procedure use at the end of life. Most prev-
ious Medicare claims studies have focused on overall inpatient
spending
18,19 and none have used multilevel modeling to
account for individual hospital effects. The study by Levinsky
et al. that analyzed ICU and life-sustaining procedure use by
age in California and Massachusetts only reported a demo-
graphic- and comorbidity-adjusted effect of black race on
spendingduetolimited sample sizeof blacks.
17 Themulticenter
Study to Understand Prognoses and Preferences for Outcomes
and Risks of Treatment (SUPPORT) trial reported that black
patients received less intervention than white patients among
their sample of seriously ill adults that included younger
patients and a mix of decedents and survivors.
42
Both end-of-life health service use and racial differences in
treatment receive a great deal of policy attention. End-of-life
utilization attracts interest because per person expenditures
for Medicare beneficiaries who die each year are 5 times higher
than for survivors.
43 Indeed, between 1985 and 1999 real
spending on inpatient services for fee-for-service decedents
increased 60%, to $23 billion in 1999.
33 This increase in
spending was neither driven by an increase in the population
nor a significant increase in the age-adjusted likelihood of
admission; instead, increases in per capita treatment intensity
explained much of this expenditure growth. Racial differences
in health service use attract interest because they may reflect
differences in access or uptake that contribute to observed
health disparities. Curiously, as reported by other authors, it is
only at the end of life that blacks appear to have greater health
servicesexpendituresthannonblacks,particularlyforinpatient
services.
17,19,44In part, thisis duetoa higherlikelihood ofdying
in the hospital.
33 Findings from the present study additionally
suggest that blacks’ greater use of intensive procedures, par-
ticularly highly remunerated (pre-2006) DRGs 475 and 483
associated with intubation/tracheostomy and mechanical ven-
tilation >96 hours, help to explain this higher spending.
The lower rates of cardiovascular and orthopedic proce-
dures among blacks have been previously documented, and
may be due to differences in physician referral
8,11,45 or to dif-
ferences in patients’ perceptions of outcomes and their atten-
dant willingness to undergo surgery.
46,47 Higher rates of
intubation and tracheostomy and feeding tube placement are
consistent with previous studies of hypothetical and real end-
of-life decisions suggesting that blacks are less likely to forego
life-sustaining treatments.
20–24,48 Higher rates of vascular and
hemodialysis access procedures and lower rates of surgical
repair of hip fracture are likely attributable to the well-docu-
mented differences in burden of vascular disease, end-stage
renal disease, and osteoporosis among blacks compared to
nonblacks.
The secular trends demonstrating a widening of the differ-
enceinend-of-life impatient treatment intensity between blacks
and nonblacks in the latter half of the 1990s could be explained
by progressively higher rates of hospice enrollment
16, 32 and
attendant limitation of ICU admission, mechanical ventilation,
and enteral feeding among nonblacks during this period.
Furthermore, the minority of U.S. hospitals that care for most
of America’s black patients are more likely to have medical
ICUs
39; other structures and processes related to treatment
intensity also likely differ.
Our study is subject to several limitations. First, our study
relies upon the frequently used “look back” approach to under-
stand how dying patients are treated, though patients may not
have been known to be “dying” at the time treatments were ini-
tiated.
49,50 Additionally, we focused only on inpatient services
and did not study trends in outpatient or postacute treatment
intensity because the hospital remains the site of the most
expensive and technologically intensive medical care. Our mea-
sures of utilization may have underestimated treatment inten-
sity by calculating the receipt of one or more ICU admission or
procedure over 12 months rather than the mean number of
admissions and procedures. Our findings for the terminal hos-
pitalization and for total expenditures which more closely track
service volume (not reported) followed the same patterns byrace
and suggest that our measure of utilization does not confound
the observations. Despite statistical adjustment for measured
confounders, the large differences in characteristics of black
and nonblack patients raise the possibility that differences are
attributable to unmeasured confounders. Finally, the observa-
tions are based only upon fee-for-service Medicare and cannot
be generalized to those in managed “risk plans.”
Our study does not offer any information about patient prefer-
ences or the appropriateness of end-of-life treatment intensity. It
does, however, raise provocative questions about differences in
practice patterns at hospitals caring for black patients that
deserve further study.
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APPENDIX
Intensive procedures included in the study
(in alphabetical order)
Amputation of lower extremity
Ankle/foot joint replacement
Aortic resection with replacement
Appendectomy
Arteriogram and venogram (not heart or head)
Automated implantable cardioverter defibrillator (AICD)
Biopsy of spinal cord
Bone marrow transplant
Cardiac assist device/ECMO/bypass
Cardiac catheterization, coronary arteriography
Carotid endarterectomy
Central vessel endarterectomy/thrombectomy
Cerebral arteriogram
Cholecystectomy and common duct exploration
Closed control of UGIB
Colon resection
Coronary artery bypass graft (CABG)
Creation of arteriovenous fistula
Cycstectomy
Electrophysiology study (EPS) +/- ablation
Enterostomy
Esophageal dilation
Esophageal reanastamosis/repair
Esophagectomy
Excision, lysis peritoneal tissue
Exploratory laparotomy
Feeding tube placement
Fundoplication
Genitourinary incontinence procedures
Hemodialysis
Hip replacement, total and partial
Hysterectomy
Ileostomy and colostomy
Injection or ligation of esophageal varices
Insert/repl/revise/remove permananent pacemaker
Insertion, temporary cardiac pacemaker
Intracoronary artery thrombolytic infusion
Intubation and Tracheostomy
Jaw fracture repair
Kidney transplant
Knee replacement
Laminectomy, diskectomy, arthrodesis
Laparoscopic cholecystectomy
Laryngectomy
Lobectomy
Local excision lung/bronchus
Mastectomy
Mastoidectomy
Mediastinoscopy
Nephrectomy
Oophorectomy, unilateral and bilateral
Open biopsy lung/bronchus
Open cholecystectomy
Open CNS biopsy
Open CNS diagnostic procedures
Open CNS therapeutic procedures
Open control of UGIB
Open heart repair of septal defects, etc.
Open or closed cardiac massage
Open Prostatectomy
Orchiectomy
Pancreatectomy/pancreaticoduodenectomy
Partial/total gastrectomy and gastric bypass
Pelvic exenteration
Percutaneous CNS biopsy (stereotactic/burr hole)
Percutaneous transluminal coronary angioplasty (PTCA)
Pericardial procedure
Peripheral vascular bypass
Peripheral vessel endarterectomy/thrombectomy
Pneumonectomy
Pyloroplasty
Radical Prostatectomy
Regional/radical lymph-node dissection
Revision/repair of vessel/vascular Procedure
Skin graft
Small bowel resection
Splenectomy
Surgical removal of urinary calculus
Thoracotomy
Thyroidectomy
Transurethral Prostatectomy (TURP)
Treatment, fracture of hip and femur
Treatment, fracture of lower extremity
Treatment, fracture of radius and ulna
Vagotomy
Valve procedures (including replacement)
Vena cava interruption
Ventricular shunt
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